Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter

被引:52
作者
Helmus, Yvonne
Denecke, Jonas
Yakubenia, Sviatlana
Robinson, Peter
Luehn, Kerstin
Watson, Diana L.
McGrogan, Paraic J.
Vestweber, Dietmar
Marquardt, Thorsten
Wild, Martin K.
机构
[1] Univ Munster, Max Planck Inst Mol Biomed, ZMBE, D-48149 Munster, Germany
[2] Univ Munster, Inst Cell Biol, ZMBE, D-48149 Munster, Germany
[3] Univ Klinikum Munster, Klin Kinder & Jugendmed, D-48149 Munster, Germany
[4] Univ Hosp, Dept Pediat, Munster, Germany
[5] Royal Hosp Sick Children, Yorkhill Natl Hlth Serv, NHS Trust, Glasgow G3 8SJ, Lanark, Scotland
关键词
D O I
10.1182/blood-2005-08-3334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease caused by defective fucosylation leading to immunodeficiency and psychomotor retardation. We have previously identified the genetic defect of LAD II in a patient whose Golgi GDP-fucose transporter (GFTP) bears a single amino acid exchange that renders this protein nonfunctional but correctly localized to the Golgi. We now report a novel dual defect by which a truncated GFTP causes the disease in a new LAD II patient. We show that the truncation renders this GFTP unable to localize to the Golgi, the compartment where it is required. Furthermore, the missing part of the GFTP can be dissected into 2 regions, one that is needed for Golgi localization and one that is additionally required for the function of the GFTP. We investigated the subcellular localization of all known defective GFTPs allowing us to divide all genetically analyzed LAD II patients into 2 groups, one in which single amino acid exchanges in the GFTP impair its function but not its subcellular localization, and another group with a dual defect in function and Golgi expression of the GFTP due to the absence of 2 important molecular regions.
引用
收藏
页码:3959 / 3966
页数:8
相关论文
共 34 条
[1]   Molecular characterization of Vig4/Vrg4 GDP-mannose transporter of the yeast Saccharomyces cerevisiae [J].
Abe, M ;
Hashimoto, H ;
Yoda, K .
FEBS LETTERS, 1999, 458 (03) :309-312
[2]   Substrate recognition by UDP-galactose and CMP-sialic acid transporters - Different sets of transmembrane helices are utilized for the specific recognition of UDP-galactose and CMP-sialic acid [J].
Aoki, K ;
Ishida, N ;
Kawakita, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :21555-21561
[3]   Expression and activity of chimeric molecules between human UDP-galactose transporter and CMP-sialic acid transporter [J].
Aoki, K ;
Sun-Wada, GH ;
Segawa, H ;
Yoshioka, S ;
Ishida, N ;
Kawakita, M .
JOURNAL OF BIOCHEMISTRY, 1999, 126 (05) :940-950
[4]   The human solute carrier gene SLC35B4 encodes a bifunctional nucleotide sugar transporter with specificity for UDP-xylose and UDP-N-acetylglucosamine [J].
Ashikov, A ;
Routier, F ;
Fuhlrott, J ;
Helmus, Y ;
Wild, M ;
Gerardy-Schahn, R ;
Bakker, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) :27230-27235
[5]   Lymphocyte homing and homeostasis [J].
Butcher, EC ;
Picker, LJ .
SCIENCE, 1996, 272 (5258) :60-66
[6]   Suppressors of α(1,3)fucosylation identified by expression cloning in the LEC11B gain-of-function CHO mutant [J].
Chen, W ;
Tang, J ;
Stanley, P .
GLYCOBIOLOGY, 2005, 15 (03) :259-269
[7]   An activated 5′ cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense-mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG-Id) [J].
Denecke, J ;
Kranz, C ;
Kemming, D ;
Koch, HG ;
Marquardt, T .
HUMAN MUTATION, 2004, 23 (05) :477-486
[8]  
Ebnet K, 2000, J BIOL CHEM, V275, P27979
[9]   Fucose supplementation in leukocyte adhesion deficiency type II [J].
Etzioni, A ;
Tonetti, M .
BLOOD, 2000, 95 (11) :3641-3642
[10]   RECURRENT SEVERE INFECTIONS CAUSED BY A NOVEL LEUKOCYTE ADHESION DEFICIENCY [J].
ETZIONI, A ;
FRYDMAN, M ;
POLLACK, S ;
AVIDOR, I ;
PHILLIPS, ML ;
PAULSON, JC ;
GERSHONIBARUCH, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (25) :1789-1792